FUZHOU, 12th June, 2026 (WAM) -- A high-level delegation of government and business leaders from Ras Al Khaimah has concluded a successful four-day tour in Guangdong and Fujian Provinces, hosting ...

A high-level delegation of government and business leaders from Ras Al Khaimah has concluded a successful four-day tour in Guangdong and Fujian Provinces, hosting business promotion conferences themed ...

LONDON: The blockade of the Strait of Hormuz has led to global energy disruptions "never seen before", the chief executive of British oil giant Shell said Wednesday (Jun 10). More than 10 per cent of ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Reliability, availability and serviceability (RAS) is not a new concept, but AI is forcing a ...

Grand Rapids, Mich. – Premium bedding products manufacturer Down Inc. has installed a unique automated pillow shell production system at its newly renovated facility. Operated by just two team members ...

The Higher Education Commission (HEC) has issued a new advisory for students planning to pursue higher education abroad, urging them to verify the approved mode of study before enrolling in foreign ...

European Commission on Wednesday proposed new rules to bolster homegrown tech. There have been growing calls for Europe to diversify away from non-European providers of critical tech as geopolitical ...

The Higher Education Commission (HEC) of Pakistan has denied reports of a database breach, stating that claims circulating on social media are false. HEC confirmed its Cyber Security Operations Center ...

Tri-complex inhibitors (TCIs) are molecular glues that bind to active GTP-bound RAS and recruit the intracellular chaperone cyclophilin A (CYPA) to generate a synthetic inhibitory complex that blocks ...

(Yicai) June 2 -- Hec Technology Holding, a Chinese electronic and new materials supplier, said its artificial intelligence computing power unit has landed a second large deal from a different ...

At the moment, RevMed remains keenly focused on its mission to bring daraxonrasib to the masses and continue developing new medicines that target RAS. (Darren Incorvaia) This year’s meeting of the ...